Phase I Trial of Suberoylanilide Hydroxamic Acid (SAHA) + Bortezomib (Bort) in Relapsed Multiple Myeloma (MM) Patients (pts).Ashraf Badros, Merrill J. Egorin, Rubén Niesvizky et al.|Blood|2007Cited by 25